Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)Ended earlyNCT01591343
What this trial is testing

Safety Study of Depigoid Vaccine Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml), to Treat Allergic Rhinitis or Rhinoconjunctivitis With or Without Asthma

Who this might be right for
Allergic RhinitisRhinoconjunctivitisMild Persistent Asthma+1 more
Laboratorios Leti, S.L. 8
Testing effectiveness (Phase 2)Study completedNCT01634958
What this trial is testing

Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Who this might be right for
Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent AsthmaSensitization Against Phleum Pratense PollenDose-Finding Study
Leti Pharma GmbH 308
Large-scale testing (Phase 3)Study completedNCT01694836
What this trial is testing

Depigoid Birch 5000 Longterm Study in Adults and Adolescents

Who this might be right for
Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent AsthmaSensitization Against Betula Alba (Birch) Pollen
Leti Pharma GmbH 634
Testing effectiveness (Phase 2)Study completedNCT01144429
What this trial is testing

Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Who this might be right for
Allergic Rhinitis and/or Rhinoconjunctivitis +- AsthmaImmunotherapy, Allergen
Leti Pharma GmbH 344
Large-scale testing (Phase 3)Study completedNCT01902992
What this trial is testing

Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch

Who this might be right for
Allergic Rhinoconjunctivitis
Novartis 202